Patients undergoing lymphadenectomy for stage III melanomas of known or unknown primary site do not differ in outcome

International Journal of Cancer

Volumn 133, Issue 12, 2013, Pages 3000-3007

  Hughes, Maria Celia ^a   Wright, Annaliesa ^b   Barbour, Andrew ^c   Thomas, Janine ^c   Smithers, B Mark ^c   Green, Adele C ^a,d   Khosrotehrani, Kiarash ^b  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

melanoma; metastasis; prognosis; survival; unknown primary

Indexed keywords

ADULT; ARTICLE; CANCER MORTALITY; CANCER OF UNKNOWN PRIMARY SITE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTATIC MELANOMA; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PREDICTOR VARIABLE; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME; TUMOR INVASION;

MELANOMA; METASTASIS; PROGNOSIS; SURVIVAL; UNKNOWN PRIMARY;

ADULT; AGED; FEMALE; HUMANS; LYMPH NODE EXCISION; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, UNKNOWN PRIMARY; TREATMENT OUTCOME;

EID: 84885577769     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28318     Document Type: Article

References (16)

1. Pfeil AF, Leiter U, Buettner PG, et al. Melanoma of unknown primary is correctly classified by the AJCC melanoma classification from 2009. Melanoma Res 2011; 21: 228-34.
2. Cormier JN, Xing Y, Feng L, et al. Metastatic melanoma to lymph nodes in patients with unknown primary sites. Cancer 2006; 106: 2012-20.
3. de Waal AC, Aben KK, van Rossum MM, et al. Melanoma of unknown primary origin: a population-based study in the Netherlands. Eur J Cancer 2013; 49: 676-83.
4. Katz KA, Jonasch E, Hodi FS, et al. Melanoma of unknown primary: experience at Massachusetts General Hospital and Dana-Farber Cancer Institute. Melanoma Res 2005; 15: 77-82.
5. Chang AE, Karnell LH, Menck HR,. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1998; 83: 1664-78.
6. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199-206.
7. Lee CC, Faries MB, Wanek LA, et al. Improved survival after lymphadenectomy for nodal metastasis from an unknown primary melanoma. J Clin Oncol 2008; 26: 535-41.
8. Prens SP, van dPAP, van AAC, et al. Outcome after therapeutic lymph node dissection in patients with unknown primary melanoma site. Ann Surg Oncol 2011; 18: 3586-92.
9. Rutkowski P, Nowecki ZI, Dziewirski W, et al. Melanoma without a detectable primary site with metastases to lymph nodes. Dermatol Surg 2010; 36: 868-76.
10. Schlagenhauff B, Stroebel W, Ellwanger U, et al. Metastatic melanoma of unknown primary origin shows prognostic similarities to regional metastatic melanoma: recommendations for initial staging examinations. Cancer 1997; 80: 60-5.
11. Anbari KK, Schuchter LM, Bucky LP, et al. Melanoma of unknown primary site: presentation, treatment, and prognosis-a single institution study. University of Pennsylvania Pigmented Lesion Study Group. Cancer 1997; 79: 1816-21.
12. Bastiaannet E, Uyl-de Groot CA, Brouwers AH, et al. Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma. Ann Surg 2012; 255: 771-6.
13. Bastiaannet E, Oyen WJ, Meijer S, et al. Impact of [18F] fluorodeoxyglucose positron emission tomography on surgical management of melanoma patients. Br J Surg 2006; 93: 243-9.
14. Ghali WA, Quan H, Brant R, et al., Investigators A. Comparison of 2 methods for calculating adjusted survival curves from proportional hazards models. J Am Med Assoc 2001; 286: 1494-7.
15. Nieto FJ, Coresh J,. Adjusting survival curves for confounders: a review and a new method. Am J Epidemiol 1996; 143: 1059-68.
16. Liu L, Forman S, Barton B,. Fitting cox model using PROC PHREG and beyond in SAS. SAS Global Forum 2009. 2009;Paper 236-2009.